Research: ANDREEVA and COLLEAGUES,

Listed in Issue 199

Abstract

ANDREEVA and COLLEAGUES, Nutritional Epidemiology Research Unit, University of Paris XIII, Bobigny, France. v.andreeva@uren.smbh.univ-paris13.fr  investigated the effects of B vitamins and omega-3 (n-3) fatty acid supplementation on cognition in a high-risk population.

Background

Rapid ageing of the population worldwide necessitates a heightened concern about preventing cognitive decline.

Methodology

This was an ancillary study of the SU.FOL.OM3 (Supplementation with FOLate, vitamins B-6 and B-12 and/or OMega-3 fatty acids) secondary prevention trial conducted in France between 2003 and 2009. The present sample included 1748 men and women aged 45-80 y with a history of myocardial infarction, unstable angina, or ischemic stroke and who were recruited via a network of 417 physicians. With the use of block randomization with stratification by sex, age, prior cardiovascular disease, and city of residence, participants were assigned in a 2 x 2 factorial design to 1 of 4 groups: 1) 5-methyltetrahydrofolate (folate, 0.56 mg) and vitamins B-6 (3 mg) and B-12 (0.02 mg), 2) eicosapentaenoic and docosahexaenoic acids (600 mg) in a 2:1 ratio, 3) B vitamins and omega-3 fatty acids, or 4) placebo. Cognitive function after 4 y of supplementation was assessed with the French version of the modified Telephone Interview for Cognitive Status.

Results

No significant main effects of group assignment on cognitive function were found; however, the authors found some evidence of disease history- and age-specific effects. In the subgroup with prior stroke, for example, participants assigned to receive B vitamins plus omega-3 fatty acids were significantly less likely to have a decreased score on the temporal orientation task than were those assigned to receive placebo (odds ratio: 0.43; 95% CI: 0.21, 0.86).

Conclusion

If present, dietary effects on cognition are likely group-specific. These results could be useful in interventions aimed at preventing cognitive decline in high-risk individuals. This trial is registered at controlled-trials.com as ISRCTN41926726.

References

Andreeva VA, Kesse-Guyot E, Barberger-Gateau P, Fezeu L, Hercberg S and Galan P. Cognitive function after supplementation with B vitamins and long-chain omega-3 fatty acids: ancillary findings from the SU.FOL.OM3 randomized trial. American Journal of Clinical Nutrition. 94(1):278-86. Jul 2011.

Munro Hall Clinic 2019

IJCA 2018 New Skyscraper

Scientific and Medical Network 2021

Cycle India 2020

Walk on the Wide Side Trek Kenya 2020

Big Heart Bike Ride South Africa 2020

top of the page